MERCK Kommanditgesellschaft auf Aktien Stock Other OTC
Equities
MKKGY
US5893392093
Pharmaceuticals
Sales 2024 * | 21.26B 22.87B | Sales 2025 * | 22.52B 24.24B | Capitalization | 66.09B 71.11B |
---|---|---|---|---|---|
Net income 2024 * | 2.96B 3.18B | Net income 2025 * | 3.49B 3.75B | EV / Sales 2024 * | 3.43 x |
Net Debt 2024 * | 6.72B 7.23B | Net Debt 2025 * | 4.9B 5.27B | EV / Sales 2025 * | 3.15 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
18.9
x | Employees | - |
Yield 2024 * |
1.51% | Yield 2025 * |
1.6% | Free-Float | 29.71% |
Latest transcript on MERCK Kommanditgesellschaft auf Aktien
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 62 | 20-07-12 | |
Marcus Kuhnert
DFI | Director of Finance/CFO | 56 | 14-07-31 |
Director of Finance/CFO | 53 | 19-04-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Raabe
BRD | Director/Board Member | - | - |
Jürgen Glaser
BRD | Director/Board Member | 61 | 12-04-30 |
Gabriele Eismann
BRD | Director/Board Member | 62 | 90-12-31 |
1st Jan change | Capi. | |
---|---|---|
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+42.38% | 4.47B | |
+4.51% | 3.96B | |
+21.10% | 2.44B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+6.53% | 1.69B |